Alpha-galactosidase A stem cell therapy (University Health Network/Ozmosis)

N/A

Report date: 2023/01/12 15:52:37

Base Information

Drug NameAlpha-galactosidase A stem cell therapy (University Health Network/Ozmosis)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionAnti-CD34
TargetsHematopoietic progenitor cell antigen CD34
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Health Network (Uhn)
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Health Network (Uhn)
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A